Cadence Pharmaceuticals, Inc. (CADX) Misses Q1 EPS by 5c; Guides Q2 Sales Below
Tweet Send to a FriendGet Alerts CADX Hot Sheet
Price: $6.91 -0.86%
Financial Fact:
Total costs and expenses: 31.55M
Today's EPS Names:
ANF, DXLG, FL, More
Financial Fact:
Total costs and expenses: 31.55M
Today's EPS Names:
ANF, DXLG, FL, More
Trade CADX Now!
Cadence Pharmaceuticals, Inc. (NASDAQ: CADX) reported Q1 EPS of ($0.27), $0.05 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $8 million versus the consensus estimate of $8.93 million.
Sees Q2 2012 revenue of $10-$10.4 million, versus the consensus of $15.0 million.
For earnings history and earnings-related data on Cadence Pharmaceuticals, Inc. (CADX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Sees Q2 2012 revenue of $10-$10.4 million, versus the consensus of $15.0 million.
For earnings history and earnings-related data on Cadence Pharmaceuticals, Inc. (CADX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- Aeropostale, Inc. (ARO) Tops Q1 EPS by 1c; Guide for Wide Q2 Loss
- Marvell Technology Group (MRVL) Tops Q1 EPS by 5c; Issues Solid Outlook
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
